{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:07Z","timestamp":1786119187234,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/mcg.0b013e3180318ac5","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T12:23:00Z","timestamp":1236255780000},"page":"373-380","source":"Crossref","is-referenced-by-count":13,"title":["Risk Factors of Peptic Ulcer in 4943 Inpatients"],"prefix":"10.1097","volume":"42","author":[{"given":"Giorgio","family":"Talamini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Amadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Pajusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fratucello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Scroccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Vantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210305","first-page":"CD002094","article-title":"Proton pump inhibitor treatment for acute peptic ulcer bleeding","author":"Leontiadis","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-10-20210305","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"R3-10-20210305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2036.2004.02042.x","article-title":"Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?","volume":"20","author":"Hawkey","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"R4-10-20210305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00019053-200119001-00005","article-title":"Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland","volume":"19","author":"Chancellor","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"R5-10-20210305","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00019053-200422100-00003","article-title":"Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK","volume":"22","author":"Moore","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"R6-10-20210305","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin, and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"R7-10-20210305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)17864-7","article-title":"Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study","volume":"365","author":"Graham","year":"2005","journal-title":"Lancet"},{"key":"R8-10-20210305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2036.2005.02554.x","article-title":"Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong","volume":"22","author":"Xia","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-10-20210305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2036.2004.02297.x","article-title":"Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection","volume":"21","author":"Perez-Aisa","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-10-20210305","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1572-0241.2006.00518.x","article-title":"Complicated and uncomplicated peptic ulcers in a Danish County 1993-2002: a population-based cohort study","volume":"101","author":"Lassen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R11-10-20210305","first-page":"29","article-title":"Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population","volume":"11","author":"Delate","year":"2005","journal-title":"Am J Manag Care"},{"issue":"5A","key":"R12-10-20210305","first-page":"63S","article-title":"Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications","volume":"117","author":"Peura","year":"2004","journal-title":"Am J Med"},{"key":"R13-10-20210305","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.dld.2004.05.011","article-title":"Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin","volume":"36","author":"Pilotto","year":"2004","journal-title":"Dig Liver Dis"},{"key":"R14-10-20210305","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1572-0241.2004.30894.x","article-title":"Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?","volume":"99","author":"Guda","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R15-10-20210305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1742-1241.2004.00298.x","article-title":"Proton pump inhibitors: a survey of prescribing in an Irish general hospital","volume":"59","author":"Mat Saad","year":"2005","journal-title":"Int J Clin Pract"},{"key":"R16-10-20210305","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.2003.01795.x","article-title":"Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs","volume":"18","author":"Sturkenboom","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-10-20210305","first-page":"263","article-title":"A practice-based approach for converting from proton pump inhibitors to less costly therapy","volume":"4","author":"Lucas","year":"2001","journal-title":"Eff Clin Pract"},{"key":"R18-10-20210305","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00045391-200309000-00005","article-title":"Impact of cotherapy with some proton pump inhibitors on medical claims among HMO patients already using other common drugs also cleared by cytochrome P450","volume":"10","author":"McCarthy","year":"2003","journal-title":"Am J Ther"},{"key":"R19-10-20210305","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jclinepi.2003.08.015","article-title":"A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults","volume":"57","author":"Valuck","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"R20-10-20210305","first-page":"CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-10-20210305","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.aje.a117469","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons","volume":"141","author":"Smalley","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R22-10-20210305","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"R23-10-20210305","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/gut.52.6.820","article-title":"Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study","volume":"52","author":"Hawkey","year":"2003","journal-title":"Gut"},{"key":"R24-10-20210305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/aje\/kwh005","article-title":"Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs","volume":"159","author":"Garcia Rodriguez","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R25-10-20210305","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.dld.2003.10.011","article-title":"Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs","volume":"36","author":"Gisbert","year":"2004","journal-title":"Dig Liver Dis"},{"key":"R26-10-20210305","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/aje\/kwj129","article-title":"Peptic ulcer disease in a general adult population","volume":"163","author":"Aro","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R27-10-20210305","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/00365520310004696","article-title":"Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers","volume":"38","author":"Konturek","year":"2003","journal-title":"Scand J Gastroenterol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004836-200804000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:42:10Z","timestamp":1786038130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-200804000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3180318ac5","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}